Open Label Single Arm Phase II Immunotherapy Trial in Patients With Cervical Cancer
Latest Information Update: 04 Nov 2021
At a glance
- Drugs V3-Cervix (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- Sponsors Immunitor
Most Recent Events
- 15 Jun 2018 New trial record